Regeneron Pharmaceuticals (REGN) Other financing activities (2013 - 2025)

Regeneron Pharmaceuticals (REGN) posted quarterly Other financing activities of -$10.3 million for Q1 2025, up 69.16% quarter-over-quarter from -$33.4 million in Q3 2024.

Regeneron Pharmaceuticals (REGN) Other financing activities (2013 - 2025) Analysis & Trends

Regeneron Pharmaceuticals' Other financing activities history runs 6 years deep, the most recent figure standing at -$10.3 million for Q1 2025.

  • In Q1 2025, Other financing activities changed N/A year-over-year to -$10.3 million; the TTM figure through Dec 2025 stood at -$10.3 million (up 69.16% YoY), while the FY2025 annual figure was -$10.3 million, up 69.16% from the prior year.
  • Other financing activities for Q1 2025 stood at -$10.3 million, up from -$33.4 million in the prior quarter.
  • The five-year high for Other financing activities was -$10.3 million in Q1 2025, with the low at -$33.4 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 -10.30 Mn
Mar 31, 2025 -10.30 Mn
Sep 30, 2024 -33.40 Mn
Sep 30, 2024 -33.40 Mn
Sep 30, 2016 8.60 Mn
Sep 30, 2016 8.60 Mn
Jun 30, 2016 39.80 Mn
Jun 30, 2016 39.80 Mn
Mar 31, 2016 15.60 Mn
Mar 31, 2016 15.60 Mn
Dec 31, 2015 99.77 Mn
Dec 31, 2015 99.77 Mn
Sep 30, 2015 56.83 Mn
Sep 30, 2015 56.83 Mn
Jun 30, 2015 78.92 Mn
Jun 30, 2015 78.92 Mn
Mar 31, 2015 169.79 Mn
Mar 31, 2015 169.79 Mn
Dec 31, 2014 105.13 Mn
Dec 31, 2014 105.13 Mn